Yumiko Azuma Selected Research

LC 6

1/2007	Parathyroid hormone-related protein induces cachectic syndromes without directly modulating the expression of hypothalamic feeding-regulating peptides.
6/2005	Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yumiko Azuma Research Topics

Disease

6	Neoplasms (Cancer) 12/2020 - 06/2005
2	Myeloid Leukemia (Leukemia, Myelocytic) 01/2019 - 01/2018
2	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2019 - 01/2018
2	Sarcoma (Soft Tissue Sarcoma) 01/2018 - 08/2014
2	Parkinsonian Disorders (Parkinsonism) 01/2017 - 01/2010
2	Melanoma (Melanoma, Malignant) 12/2008 - 05/2007
2	Leukemia 05/2007 - 12/2004
2	Humoral Hypercalcemia Of Malignancy 01/2007 - 06/2005
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2019
1	Liposarcoma 01/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2018
1	Hematologic Neoplasms (Hematological Malignancy) 10/2017
1	Nervous System Diseases (Neurological Disorders) 01/2017
1	Parkinson Disease (Parkinson's Disease) 01/2017
1	Hemolytic Anemia 01/2017
1	Muscular Diseases (Myopathy) 01/2017
1	Glycogen Storage Disease Type II (Pompe's Disease) 06/2014
1	Disease Progression 01/2010
1	Muscle Weakness 01/2009
1	Polymyositis 01/2009
1	Dermatomyositis (Dermatopolymyositis) 01/2009
1	Renal Cell Carcinoma (Grawitz Tumor) 12/2008
1	Multiple Myeloma 12/2008
1	Pheochromocytoma 10/2007
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2007
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2007
1	Anorexia 01/2007
1	AIDS-Related Complex (ARC) 01/2007
1	Bone Resorption 06/2005
1	Lymphoma (Lymphomas) 12/2004

Drug/Important Bio-Agent (IBA)

3	AntigensIBA 12/2020 - 12/2008
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2017
3	Monoclonal AntibodiesIBA 12/2008 - 05/2007
2	Adenosine Triphosphate (ATP)IBA 12/2020 - 01/2017
2	NucleophosminIBA 01/2019 - 01/2018
2	LC 6IBA 01/2007 - 06/2005
2	Parathyroid Hormone-Related ProteinIBA 01/2007 - 06/2005
1	AntibodiesIBA 12/2020
1	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2018
1	Solute Carrier ProteinsIBA 01/2018
1	blinatumomabIBA 10/2017
1	Immune Checkpoint InhibitorsIBA 10/2017
1	Programmed Cell Death 1 ReceptorIBA 10/2017
1	GlypicansIBA 10/2017
1	VaccinesIBA 10/2017
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2017
1	3-Iodobenzylguanidine (Iobenguane)IBA 01/2017
1	Levodopa (L Dopa)FDA LinkGeneric 01/2017
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 08/2014
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2010
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2010
1	Prednisolone (Predate)FDA LinkGeneric 01/2009
1	Phosphotransferases (Kinase)IBA 01/2009
1	CreatinineIBA 01/2009
1	I-antigenIBA 01/2009
1	Histocompatibility Antigens Class IIBA 01/2009
1	InterferonsIBA 12/2008
1	Bone Marrow Stromal Antigen 2IBA 12/2008
1	Interferon-alpha (Interferon Alfa)IBA 12/2008
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 10/2007
1	G(M3) GangliosideIBA 05/2007
1	Immunoglobulin M (IgM)IBA 05/2007
1	Complement System Proteins (Complement)IBA 05/2007
1	fludarabineIBA 05/2007
1	Neuropeptide YIBA 01/2007
1	Peptides (Polypeptides)IBA 01/2007
1	LeptinIBA 01/2007
1	Amphetamine (Amfetamine)FDA LinkGeneric 01/2007
1	Corticotropin-Releasing HormoneIBA 01/2007
1	Agouti-Related ProteinIBA 01/2007
1	Messenger RNA (mRNA)IBA 01/2007
1	Cocaine (Cocaine HCl)IBA 01/2007
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 01/2007
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 06/2005
1	Diphosphonates (Bisphosphonates)IBA 06/2005
1	Bone Density Conservation AgentsIBA 06/2005
1	Pharmaceutical PreparationsIBA 06/2005
1	CalciumIBA 06/2005
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 06/2005
1	MitogensIBA 12/2004

Therapy/Procedure

1	Therapeutics 01/2018
1	Immunotherapy 10/2017
1	Enzyme Replacement Therapy 06/2014
1	Ligation 05/2007